New models of drug-resistant breast cancer point to better treatments

New models of drug-resistant breast cancer point to better treatments Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research from Washington University School of Medicine (home of the … Continue reading “New models of drug-resistant breast cancer point to better treatments”

New models of drug-resistant breast cancer point to better treatments

Human breast tumors transplanted into mice are excellent models of metastatic cancer and are providing insights into how to attack breast cancers that no longer respond to the drugs used to treat them, according to research from Washington University School of Medicine (home of the Alvin J. Siteman Cancer Center) in St. Louis, presented Dec. 12 at the San Antonio Breast Cancer Symposium.

Click here to read full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 68 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.

Author: Joe Lovrek

Born in Houston, Raised in Trinity Texas

Leave a Reply